Cuicui L. Lyu

Tianjin, 300192, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Efficacy analysis of CAR-T cells against CD123-positive malignant tumors and exploration of the feasibility of combination therapy with venetoclax.

Efficacy analysis of CAR-T cells against CD123-positive malignant tumors and exploration of the feasibility of combination therapy with venetoclax.

Journal: Annals of hematology

Published: March 30, 2026

Defining a Therapeutic Window for Venetoclax in Post-Transplant Maintenance Therapy for High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Defining a Therapeutic Window for Venetoclax in Post-Transplant Maintenance Therapy for High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Journal: Hematological oncology

Published: February 17, 2026

Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.

Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed/refractory acute myeloid leukemia.

Journal: Journal of hematology & oncology

Published: September 02, 2025

Metagenomics next-generation sequencing of plasma combined with blood cells for improving the prognosis of early infection in patients with hematologic disorders: a real-world cohort study in northern China.

Metagenomics next-generation sequencing of plasma combined with blood cells for improving the prognosis of early infection in patients with hematologic disorders: a real-world cohort study in northern China.

Journal: Frontiers in molecular biosciences

Published: July 29, 2025

Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.

Efficacy and safety of tocilizumab in managing cytokine release syndrome after CD19 CAR-T therapy for relapsed or refractory B-cell acute lymphoblastic leukemia.

Journal: Frontiers in immunology

Published: November 19, 2024

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.

Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.

Journal: Frontiers in immunology

Published: September 04, 2024

Targeting CD19 CAR-T With MND Promoter Enhances Tumour Killing.

Targeting CD19 CAR-T With MND Promoter Enhances Tumour Killing.

Journal: Journal of cellular and molecular medicine

Published: July 17, 2024

Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia.

Granulocyte colony-stimulating factor in neutropenia management after CAR-T cell therapy: A safety and efficacy evaluation in refractory/relapsed B-cell acute lymphoblastic leukemia.

Journal: Chinese medical journal

Published: May 07, 2024

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy.

Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy.

Journal: Annals of hematology

Published: October 25, 2023

A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.

A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.

Journal: Cancer immunology, immunotherapy : CII

Published: August 20, 2023

The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.

The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.

Journal: BMC medical genomics

Published: July 06, 2023

Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant.

Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant.

Journal: Cell transplantation

Published: March 07, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026